Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Robert E. Kelley
Introduction
Robert E. Kelley, located in Orange, California, is a notable inventor recognized for his significant contributions to the field of immunology. With one patent to his name, Kelley has made strides in enhancing human immune responses through innovative applications of amino acids.
Latest Patents
Kelley’s patent focuses on the use of arginine as an immunostimulator. The invention pertains to the treatment of impaired human immune responses and seeks to mitigate the severity of immune degradation. By administering arginine, ornithine, or their functional analogs—either enterally through dietary compositions or parenterally through amino acid solutions—patients suffering from impaired immunity can potentially achieve better health outcomes. This innovative treatment method opens new avenues for addressing immune deficiencies.
Career Highlights
Robert E. Kelley has built a commendable career at McGaw, Inc., where he has actively worked on developments that intersect pharmacology and nutritional science. His focus on the biochemical effects of arginine signifies his commitment to advancing medical technologies aimed at enhancing human health.
Collaborations
During his tenure at McGaw, Inc., Kelley has collaborated with renowned colleagues such as Norman N. Yoshimura and Adrian Barbul. These partnerships have been instrumental in expanding the scope of research and fostering innovation within the company, leading to breakthroughs in the application of immune-enhancing compounds.
Conclusion
Robert E. Kelley’s work exemplifies the impact of scientific innovation on healthcare. Through his dedication and research on amino acids, he not only contributes to the field of immunology but also inspires future advancements that could improve human health responses. His patent on the use of arginine marks a significant milestone in the ongoing quest for effective treatments for those with compromised immune systems.